Posted by Michael Wonder on 22 Oct 2020
Nexplanon recommended after second submission
22 October 2020 - The first submission was withdrawn.
The CADTH Canadian Drug Expert Committee had recommended that etonogestrel extended-release radiopaque subdermal implant should be reimbursed for the prevention of pregnancy for up to three years only if one condition is met.
Yet again, the condition relates to price.
